MedCity News
MARCH 7, 2025
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
European Pharmaceutical Review
MARCH 7, 2025
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug for use in the UK in August 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 7, 2025
[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar with Elation Health executives Dr Sara Pastoor, head of primary care advancement, and Meaghan Sullivan, senior sales engineer. The post How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout? appeared first on MedCity News.
Impetus Digital
MARCH 7, 2025
Pharma-exclusive Webinar: From Clicks to Outcomes: Measuring the Impact of Your Medical Education Platform About the webinar Tired of building medical education programs that fail to deliver? Impetus Digital invites you to our free webinar on May 13 and 14 , designed specifically for life science professionals who are ready to build a medical education platform that truly engages HCPs and drives measurable results.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
MARCH 7, 2025
[Sponsored] In a webinar sponsored byJotform, scheduled for Thursday, March 13 at 1 pm ET, panelists will discuss how health tech companies approach data automation and how practices implement it. The post Making Automation a Mainstream Function in Healthcare Practices appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 7, 2025
GEM HEALTH’s Series A round was co-led by HealthTrend Capital and LFE Capital and included participation from existing investors Base10 Partners and Mairs & Power Venture Capital. The post GEM HEALTH Secures $7M to Advance Virtual Sleep Care appeared first on MedCity News.
pharmaphorum
MARCH 7, 2025
An observational study backed by Biogen has suggested that Apple smartphones and watches may be able to spot the signs of mild cognitive impairment
MedCity News
MARCH 7, 2025
How do we tip the scale to lower the rate of denials? While AI has been the initial decision-maker for years, it must become better trained. And to do that, it needs help. The post Better AI + Correct Provider Guidance = Fewer Denials appeared first on MedCity News.
PharmaTech
MARCH 7, 2025
Being fully versed on the ins and outs of design quality can improve the project design phase life cycle.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
pharmaphorum
MARCH 7, 2025
Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia type 2
Pharmaceutical Technology
MARCH 7, 2025
NICE previously rejected Leqembi and Kisunla for NHS coverage in August and October 2024, respectively.
pharmaphorum
MARCH 7, 2025
Johnson & Johnson has halted the development of aticaprant as a treatment for major depressive disorder, blowing a hole in its late-stage pipeline
PharmaTech
MARCH 7, 2025
The 4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
MARCH 7, 2025
The US FDA has approved scPharmaceuticals sNDA for Furoscix, expanding its indication to include oedema treatment in individuals with CKD.
Pharmacy Times
MARCH 7, 2025
The cancers linked with per- and polyfluoroalkyl substance (PFAS) exposure included nonastrocytoma gliomas, acute myeloid leukemia, and Wilms tumors.
Pharmaceutical Technology
MARCH 7, 2025
The FDA has granted orphan drug designation to Plus Therapeutics injectable radiotherapy, Rhenium (186Re) Obisbemeda.
PharmaTech
MARCH 7, 2025
The detector features specialized, solid-state dual infrared (IR) sources and dual IR receivers which provide continual cross-checks and internal adjustments to adhere to factory calibration.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Technology
MARCH 7, 2025
Closing the gap in health interventions between men and women could add $1tn to the global GDP, unlocking seven additional years for women.
PharmExec
MARCH 7, 2025
Clinical trial results found that a majority of patients with atopic dermatitis who were treated with Ebgylss achieved complete or near complete skin clearance at three years on a single monthly maintenance dose.
Pharmaceutical Technology
MARCH 7, 2025
Astellas Pharma and Yaskawa have agreed to form a JV that will focus on developing a cell therapy product manufacturing platform.
PharmExec
MARCH 7, 2025
Five-year data from Phase III trials demonstrated that 67.7% of patients moderate-to-severe plaque psoriasis treated with UCBs Bimzelx achieved complete skin clearance.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
MARCH 7, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, describes how the software companys solution can help deliver better patient outcomes and substantial savings for healthcare plans, employers, and members alike.
PharmExec
MARCH 7, 2025
Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses the promising results of DB-OTO in the CHORD trial for children with otoferlin-related hearing loss.
Pharmaceutical Commerce
MARCH 7, 2025
The latest news for pharma industry insiders.
PharmExec
MARCH 7, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
Pharmaceutical Technology
MARCH 7, 2025
How to ensure safety and quality in pharmaceutical facilities when using HPAPIs in drug development. Read more here.
PharmExec
MARCH 7, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MARCH 7, 2025
A tumour-on-chip model on PDAC has been developed to allow insights into interactions between tumour cells and potential treatments.
Expert insights. Personalized for you.
274 
Let's personalize your content